HomeNVCT • NASDAQ
Follow
Nuvectis Pharma Inc
Previous close
$8.34
Day range
$8.16 - $8.74
Year range
$6.20 - $18.65
Market cap
145.70M USD
Avg Volume
131.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.87M | 5.16% |
Net income | -6.62M | 1.11% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.13M | -4.34% |
Total assets | 19.18M | -5.98% |
Total liabilities | 6.98M | 12.90% |
Total equity | 12.20M | — |
Shares outstanding | 17.77M | — |
Price to book | 11.91 | — |
Return on assets | -70.76% | — |
Return on capital | -101.53% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -6.62M | 1.11% |
Cash from operations | -3.85M | -9.50% |
Cash from investing | — | — |
Cash from financing | 917.00K | 800.00% |
Net change in cash | -2.93M | 19.58% |
Free cash flow | -909.25K | -83.22% |
About
Founded
2020
Headquarters
Website
Employees
13